Search

Your search keyword '"A. Mohar-Betancourt"' showing total 390 results

Search Constraints

Start Over You searched for: Author "A. Mohar-Betancourt" Remove constraint Author: "A. Mohar-Betancourt"
390 results on '"A. Mohar-Betancourt"'

Search Results

1. Uptake of Risk-Reducing Surgeries in an International Real-World Cohort of Hispanic Women

2. Uptake of Risk-Reducing Surgeries in an International Real-World Cohort of Hispanic Women

Catalog

Books, media, physical & digital resources

3. Deep DNA sequencing of MGMT, TP53 and AGT in Mexican astrocytoma patients identifies an excess of genetic variants in women and a predictive biomarker

4. Health system financing fragmentation and maternal mortality transition in Mexico, 2000–2022.

5. Epidemiology of Brain Tumors

6. Análisis de la mortalidad por cáncer en México utilizando los resultados del Global Burden of Disease 2021

7. Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer

8. Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma

10. Lung cancer mortality trends in Mexico, 1998–2018: the impact of the General Law on Tobacco Control

11. Effect of complementary Integrative Oncology on anxiety, depression and quality of life in thoracic cancer patients: A pilot study

17. Cervical Cancer Epidemiology

19. Prognostic factors in patients with breast cancer and brain metastasis as the first site of recurrence

20. Cancer Trends in Mexico: Essential Data for the Creation and Follow-Up of Public Policies

21. Oncoguía de mieloma múltiple 2023

24. Challenges in the development and implementation of the National Comprehensive Cancer Control Program in Mexico

25. The importance of registries in cancer control

26. Estimating the indirect costs associated with the expected number of cancer cases in Mexico by 2020

27. Utilization of hospital services for cancer care in Mexico

28. Integrated oncology and palliative care: five years experience at the National Cancer Institute of Mexico

29. Influence of Germline BRCA Genotype on the Survival of Patients with Triple-Negative Breast Cancer

31. Deep DNA sequencing of MGMT, TP53 and AGT in Mexican astrocytoma patients identifies an excess of genetic variants in women and a predictive biomarker

32. Cancer burden in Mexico: urgent challenges to be met

33. IJMS Supplementary material

34. In situ and invasive carcinoma identified through an opportunistic screening mammography in asymptomatic women of Mexico City.

35. Abstract PS8-15: The spectrum of germline susceptibility gene variants in Mexican patients with breast cancer (BC): A Prospective Multicenter study

37. Factor Structure and Reliability of MOS Social Support Survey among Mexican Women with Breast Cancer

38. Abstract 2214: Disparity in the uptake of risk-reducing surgery after GCRA in Hispanic patients in Latin America and in the United States

42. Factores de riesgo de cáncer cervicouterino invasor en mujeres mexicanas Risk factors in invasive cervical cancer among Mexican women

43. Abstract P2-13-08: Biopsychosocial changes since diagnosis and the time taking endocrine therapy in Mexican patients with breast cancer

44. Medical care costs incurred by patients with smoking-related non-small cell lung cancer treated at the National Cancer Institute of Mexico

45. Influence of Germline BRCA Genotype on the Survival of Patients with Triple-Negative Breast Cancer

48. Additional file 2 of Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer

49. Additional file 1 of Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer

50. Additional file 3 of Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer